Question special
Lead Moderator

Hello, everyone! This is Perry Tsai, an MD/PhD student at the University of North Carolina at Chapel Hill; and I will be the lead moderator for this discussion on the article outlining the results of IPERGAY trial investigating on-demand pre-exposure prophylaxis. First, a welcome and a thank you to the authors (Drs. Molina, Spire, Tremblay, and Wainberg) and to all of the experts joining our discussion this week. We look forward to hearing your thoughts.

Let's get some initial reactions to the article. Were you surprised by the results, or did they fall within your expectations? Does the conclusion of the authors generate excitement, relief, concern in your field or practice? What have some of your conversations sounded like with colleagues or patients about the results?